These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28591789)

  • 41. Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
    Louie T; Nord CE; Talbot GH; Wilcox M; Gerding DN; Buitrago M; Kracker H; Charef P; Cornely OA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6266-73. PubMed ID: 26248357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile.
    Salgado CD; Giannetta ET; Farr BM
    Infect Control Hosp Epidemiol; 2004 May; 25(5):413-7. PubMed ID: 15188848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relapsing infections with Clostridium difficile].
    Visser WE; Dingemans-Dumas AM; Bac DJ
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2381-5. PubMed ID: 16277125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of recurrent Clostridium difficile diarrhoea using sequential therapy with vancomycin followed by rifaximin].
    Zelada Rodríguez MA; Rodríguez D; Martí X; Espejo E
    Rev Esp Geriatr Gerontol; 2012; 47(1):42-4. PubMed ID: 22105006
    [No Abstract]   [Full Text] [Related]  

  • 45. Review: NAATs diagnose C difficile; vancomycin improves cure, and fidaxomicin reduces recurrence.
    Zar FA
    Ann Intern Med; 2016 Jul; 165(2):JC4. PubMed ID: 27429316
    [No Abstract]   [Full Text] [Related]  

  • 46. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
    Cober ED; Malani PN
    J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clostridium difficile recurrences in Stockholm.
    Sandell S; Rashid MU; Jorup-Rönström C; Ellström K; Nord CE; Weintraub A
    Anaerobe; 2016 Apr; 38():97-102. PubMed ID: 26802875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: a spatial and time series analysis.
    Polgreen PM; Yang M; Kuntz JL; Laxminarayan R; Cavanaugh JE
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):723-6. PubMed ID: 21666407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Clostridium difficile recurrence on hospital readmissions.
    Olsen MA; Yan Y; Reske KA; Zilberberg M; Dubberke ER
    Am J Infect Control; 2015 Apr; 43(4):318-22. PubMed ID: 25690876
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The search for effective treatment of Clostridium difficile infection.
    DuPont HL
    N Engl J Med; 2011 Feb; 364(5):473-5. PubMed ID: 21288079
    [No Abstract]   [Full Text] [Related]  

  • 51. Clostridium difficile disease: diagnosis and treatment.
    Surawicz CM
    Gastroenterologist; 1998 Mar; 6(1):60-5. PubMed ID: 9531117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fidaxomicin for Clostridium difficile infection.
    Linsky A; Gupta K; Hermos JA
    N Engl J Med; 2011 May; 364(19):1875; author reply 1875-6. PubMed ID: 21561361
    [No Abstract]   [Full Text] [Related]  

  • 53. Extended duration vancomycin in recurrent
    Murphy MM; Patatanian E; Gales MA
    Ther Adv Infect Dis; 2018 Nov; 5(6):111-119. PubMed ID: 30430009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
    Siller-Ruiz M; Calvo-García N; Hernández-Egido S; María-Blázquez A; de Frutos-Serna M; García-Sánchez JE
    Rev Esp Quimioter; 2014 Jun; 27(2):122-6. PubMed ID: 24940894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
    Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
    Poeran J; Mazumdar M; Rasul R; Meyer J; Sacks HS; Koll BS; Wallach FR; Moskowitz A; Gelijns AC
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):589-97.e2. PubMed ID: 26545971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of treatment variation on outcomes in patients with Clostridium difficile.
    Brown AT; Seifert CF
    Am J Med; 2014 Sep; 127(9):865-70. PubMed ID: 24862310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
    Pépin J; Valiquette L; Alary ME; Villemure P; Pelletier A; Forget K; Pépin K; Chouinard D
    CMAJ; 2004 Aug; 171(5):466-72. PubMed ID: 15337727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of LFF571 and vancomycin in patients with moderate Clostridium difficile infections.
    Bhansali SG; Mullane K; Ting LS; Leeds JA; Dabovic K; Praestgaard J; Pertel P
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1441-5. PubMed ID: 25534724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vancomycin Enema in the Treatment of
    Fawley J; Napolitano LM
    Surg Infect (Larchmt); 2019; 20(4):311-316. PubMed ID: 30716016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.